Global Radio Pharmaceutical Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Radio Pharmaceutical market report explains the definition, types, applications, major countries, and major players of the Radio Pharmaceutical market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • IBA Dosimetry GmbH

    • Sun Pharmaceutical Industries Ltd

    • Mallinckrodt Pharmaceuticals

    • Medtronic

    • Avid Radiopharmaceuticals

    • General Electric Company (GE Healthcare)

    • Jubilant Life Sciences Ltd

    • Bracco Diagnostic Inc

    • Canadian Nuclear Laboratories (CNL)

    • Advanced Accelerator Applications SA

    • Nordion Inc

    • Lantheus Medical Imaging Inc

    • Siemens AG

    • Cardinal Health Inc

    • Bayer AG

    By Type:

    • Myocardial Perfusion Scan

    • Lung Scan

    • Others

    By End-User:

    • Oncology

    • Cardiology

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Radio Pharmaceutical Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Radio Pharmaceutical Outlook to 2028- Original Forecasts

    • 2.2 Radio Pharmaceutical Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Radio Pharmaceutical Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Radio Pharmaceutical Market- Recent Developments

    • 6.1 Radio Pharmaceutical Market News and Developments

    • 6.2 Radio Pharmaceutical Market Deals Landscape

    7 Radio Pharmaceutical Raw Materials and Cost Structure Analysis

    • 7.1 Radio Pharmaceutical Key Raw Materials

    • 7.2 Radio Pharmaceutical Price Trend of Key Raw Materials

    • 7.3 Radio Pharmaceutical Key Suppliers of Raw Materials

    • 7.4 Radio Pharmaceutical Market Concentration Rate of Raw Materials

    • 7.5 Radio Pharmaceutical Cost Structure Analysis

      • 7.5.1 Radio Pharmaceutical Raw Materials Analysis

      • 7.5.2 Radio Pharmaceutical Labor Cost Analysis

      • 7.5.3 Radio Pharmaceutical Manufacturing Expenses Analysis

    8 Global Radio Pharmaceutical Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Radio Pharmaceutical Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Radio Pharmaceutical Export by Region (Top 10 Countries) (2017-2028)

    9 Global Radio Pharmaceutical Market Outlook by Types and Applications to 2022

    • 9.1 Global Radio Pharmaceutical Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Myocardial Perfusion Scan Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lung Scan Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Radio Pharmaceutical Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Radio Pharmaceutical Market Analysis and Outlook till 2022

    • 10.1 Global Radio Pharmaceutical Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Radio Pharmaceutical Consumption (2017-2022)

      • 10.2.2 Canada Radio Pharmaceutical Consumption (2017-2022)

      • 10.2.3 Mexico Radio Pharmaceutical Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.2 UK Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.3 Spain Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.4 Belgium Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.5 France Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.6 Italy Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.7 Denmark Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.8 Finland Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.9 Norway Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.10 Sweden Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.11 Poland Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.12 Russia Radio Pharmaceutical Consumption (2017-2022)

      • 10.3.13 Turkey Radio Pharmaceutical Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.2 Japan Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.3 India Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.4 South Korea Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.5 Pakistan Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.6 Bangladesh Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.7 Indonesia Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.8 Thailand Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.9 Singapore Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.10 Malaysia Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.11 Philippines Radio Pharmaceutical Consumption (2017-2022)

      • 10.4.12 Vietnam Radio Pharmaceutical Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.2 Colombia Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.3 Chile Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.4 Argentina Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.5 Venezuela Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.6 Peru Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.7 Puerto Rico Radio Pharmaceutical Consumption (2017-2022)

      • 10.5.8 Ecuador Radio Pharmaceutical Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Radio Pharmaceutical Consumption (2017-2022)

      • 10.6.2 Kuwait Radio Pharmaceutical Consumption (2017-2022)

      • 10.6.3 Oman Radio Pharmaceutical Consumption (2017-2022)

      • 10.6.4 Qatar Radio Pharmaceutical Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Radio Pharmaceutical Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Radio Pharmaceutical Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Radio Pharmaceutical Consumption (2017-2022)

      • 10.7.2 South Africa Radio Pharmaceutical Consumption (2017-2022)

      • 10.7.3 Egypt Radio Pharmaceutical Consumption (2017-2022)

      • 10.7.4 Algeria Radio Pharmaceutical Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Radio Pharmaceutical Consumption (2017-2022)

      • 10.8.2 New Zealand Radio Pharmaceutical Consumption (2017-2022)

    11 Global Radio Pharmaceutical Competitive Analysis

    • 11.1 IBA Dosimetry GmbH

      • 11.1.1 IBA Dosimetry GmbH Company Details

      • 11.1.2 IBA Dosimetry GmbH Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 IBA Dosimetry GmbH Radio Pharmaceutical Main Business and Markets Served

      • 11.1.4 IBA Dosimetry GmbH Radio Pharmaceutical Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sun Pharmaceutical Industries Ltd

      • 11.2.1 Sun Pharmaceutical Industries Ltd Company Details

      • 11.2.2 Sun Pharmaceutical Industries Ltd Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sun Pharmaceutical Industries Ltd Radio Pharmaceutical Main Business and Markets Served

      • 11.2.4 Sun Pharmaceutical Industries Ltd Radio Pharmaceutical Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Mallinckrodt Pharmaceuticals

      • 11.3.1 Mallinckrodt Pharmaceuticals Company Details

      • 11.3.2 Mallinckrodt Pharmaceuticals Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Mallinckrodt Pharmaceuticals Radio Pharmaceutical Main Business and Markets Served

      • 11.3.4 Mallinckrodt Pharmaceuticals Radio Pharmaceutical Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Medtronic

      • 11.4.1 Medtronic Company Details

      • 11.4.2 Medtronic Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Medtronic Radio Pharmaceutical Main Business and Markets Served

      • 11.4.4 Medtronic Radio Pharmaceutical Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Avid Radiopharmaceuticals

      • 11.5.1 Avid Radiopharmaceuticals Company Details

      • 11.5.2 Avid Radiopharmaceuticals Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Avid Radiopharmaceuticals Radio Pharmaceutical Main Business and Markets Served

      • 11.5.4 Avid Radiopharmaceuticals Radio Pharmaceutical Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 General Electric Company (GE Healthcare)

      • 11.6.1 General Electric Company (GE Healthcare) Company Details

      • 11.6.2 General Electric Company (GE Healthcare) Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 General Electric Company (GE Healthcare) Radio Pharmaceutical Main Business and Markets Served

      • 11.6.4 General Electric Company (GE Healthcare) Radio Pharmaceutical Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Jubilant Life Sciences Ltd

      • 11.7.1 Jubilant Life Sciences Ltd Company Details

      • 11.7.2 Jubilant Life Sciences Ltd Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Jubilant Life Sciences Ltd Radio Pharmaceutical Main Business and Markets Served

      • 11.7.4 Jubilant Life Sciences Ltd Radio Pharmaceutical Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Bracco Diagnostic Inc

      • 11.8.1 Bracco Diagnostic Inc Company Details

      • 11.8.2 Bracco Diagnostic Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Bracco Diagnostic Inc Radio Pharmaceutical Main Business and Markets Served

      • 11.8.4 Bracco Diagnostic Inc Radio Pharmaceutical Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Canadian Nuclear Laboratories (CNL)

      • 11.9.1 Canadian Nuclear Laboratories (CNL) Company Details

      • 11.9.2 Canadian Nuclear Laboratories (CNL) Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Canadian Nuclear Laboratories (CNL) Radio Pharmaceutical Main Business and Markets Served

      • 11.9.4 Canadian Nuclear Laboratories (CNL) Radio Pharmaceutical Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Advanced Accelerator Applications SA

      • 11.10.1 Advanced Accelerator Applications SA Company Details

      • 11.10.2 Advanced Accelerator Applications SA Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Advanced Accelerator Applications SA Radio Pharmaceutical Main Business and Markets Served

      • 11.10.4 Advanced Accelerator Applications SA Radio Pharmaceutical Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Nordion Inc

      • 11.11.1 Nordion Inc Company Details

      • 11.11.2 Nordion Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Nordion Inc Radio Pharmaceutical Main Business and Markets Served

      • 11.11.4 Nordion Inc Radio Pharmaceutical Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Lantheus Medical Imaging Inc

      • 11.12.1 Lantheus Medical Imaging Inc Company Details

      • 11.12.2 Lantheus Medical Imaging Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Lantheus Medical Imaging Inc Radio Pharmaceutical Main Business and Markets Served

      • 11.12.4 Lantheus Medical Imaging Inc Radio Pharmaceutical Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Siemens AG

      • 11.13.1 Siemens AG Company Details

      • 11.13.2 Siemens AG Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Siemens AG Radio Pharmaceutical Main Business and Markets Served

      • 11.13.4 Siemens AG Radio Pharmaceutical Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Cardinal Health Inc

      • 11.14.1 Cardinal Health Inc Company Details

      • 11.14.2 Cardinal Health Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Cardinal Health Inc Radio Pharmaceutical Main Business and Markets Served

      • 11.14.4 Cardinal Health Inc Radio Pharmaceutical Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Bayer AG

      • 11.15.1 Bayer AG Company Details

      • 11.15.2 Bayer AG Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Bayer AG Radio Pharmaceutical Main Business and Markets Served

      • 11.15.4 Bayer AG Radio Pharmaceutical Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Radio Pharmaceutical Market Outlook by Types and Applications to 2028

    • 12.1 Global Radio Pharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Myocardial Perfusion Scan Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Lung Scan Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Radio Pharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Radio Pharmaceutical Market Analysis and Outlook to 2028

    • 13.1 Global Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.2.2 Canada Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.2 UK Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.3 Spain Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.5 France Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.6 Italy Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.8 Finland Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.9 Norway Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.11 Poland Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.12 Russia Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.2 Japan Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.3 India Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.3 Chile Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.6 Peru Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.6.3 Oman Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Radio Pharmaceutical Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Radio Pharmaceutical Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Radio Pharmaceutical Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Radio Pharmaceutical

    • Figure of Radio Pharmaceutical Picture

    • Table Global Radio Pharmaceutical Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Radio Pharmaceutical Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Myocardial Perfusion Scan Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Scan Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Radio Pharmaceutical Consumption by Country (2017-2022)

    • Table North America Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure United States Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Canada Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Mexico Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Europe Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure Germany Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure UK Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Spain Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Belgium Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure France Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Italy Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Denmark Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Finland Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Norway Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Sweden Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Poland Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Russia Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Turkey Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table APAC Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure China Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Japan Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure India Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure South Korea Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Thailand Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Singapore Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Philippines Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table South America Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure Brazil Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Colombia Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Chile Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Argentina Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Peru Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table GCC Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure Bahrain Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Oman Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Qatar Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Africa Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure Nigeria Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure South Africa Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Egypt Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Algeria Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Oceania Radio Pharmaceutical Consumption by Country (2017-2022)

    • Figure Australia Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Radio Pharmaceutical Consumption and Growth Rate (2017-2022)

    • Table IBA Dosimetry GmbH Company Details

    • Table IBA Dosimetry GmbH Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Dosimetry GmbH Radio Pharmaceutical Main Business and Markets Served

    • Table IBA Dosimetry GmbH Radio Pharmaceutical Product Portfolio

    • Table Sun Pharmaceutical Industries Ltd Company Details

    • Table Sun Pharmaceutical Industries Ltd Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Ltd Radio Pharmaceutical Main Business and Markets Served

    • Table Sun Pharmaceutical Industries Ltd Radio Pharmaceutical Product Portfolio

    • Table Mallinckrodt Pharmaceuticals Company Details

    • Table Mallinckrodt Pharmaceuticals Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt Pharmaceuticals Radio Pharmaceutical Main Business and Markets Served

    • Table Mallinckrodt Pharmaceuticals Radio Pharmaceutical Product Portfolio

    • Table Medtronic Company Details

    • Table Medtronic Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medtronic Radio Pharmaceutical Main Business and Markets Served

    • Table Medtronic Radio Pharmaceutical Product Portfolio

    • Table Avid Radiopharmaceuticals Company Details

    • Table Avid Radiopharmaceuticals Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Avid Radiopharmaceuticals Radio Pharmaceutical Main Business and Markets Served

    • Table Avid Radiopharmaceuticals Radio Pharmaceutical Product Portfolio

    • Table General Electric Company (GE Healthcare) Company Details

    • Table General Electric Company (GE Healthcare) Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table General Electric Company (GE Healthcare) Radio Pharmaceutical Main Business and Markets Served

    • Table General Electric Company (GE Healthcare) Radio Pharmaceutical Product Portfolio

    • Table Jubilant Life Sciences Ltd Company Details

    • Table Jubilant Life Sciences Ltd Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Life Sciences Ltd Radio Pharmaceutical Main Business and Markets Served

    • Table Jubilant Life Sciences Ltd Radio Pharmaceutical Product Portfolio

    • Table Bracco Diagnostic Inc Company Details

    • Table Bracco Diagnostic Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Diagnostic Inc Radio Pharmaceutical Main Business and Markets Served

    • Table Bracco Diagnostic Inc Radio Pharmaceutical Product Portfolio

    • Table Canadian Nuclear Laboratories (CNL) Company Details

    • Table Canadian Nuclear Laboratories (CNL) Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Canadian Nuclear Laboratories (CNL) Radio Pharmaceutical Main Business and Markets Served

    • Table Canadian Nuclear Laboratories (CNL) Radio Pharmaceutical Product Portfolio

    • Table Advanced Accelerator Applications SA Company Details

    • Table Advanced Accelerator Applications SA Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Accelerator Applications SA Radio Pharmaceutical Main Business and Markets Served

    • Table Advanced Accelerator Applications SA Radio Pharmaceutical Product Portfolio

    • Table Nordion Inc Company Details

    • Table Nordion Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Inc Radio Pharmaceutical Main Business and Markets Served

    • Table Nordion Inc Radio Pharmaceutical Product Portfolio

    • Table Lantheus Medical Imaging Inc Company Details

    • Table Lantheus Medical Imaging Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging Inc Radio Pharmaceutical Main Business and Markets Served

    • Table Lantheus Medical Imaging Inc Radio Pharmaceutical Product Portfolio

    • Table Siemens AG Company Details

    • Table Siemens AG Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens AG Radio Pharmaceutical Main Business and Markets Served

    • Table Siemens AG Radio Pharmaceutical Product Portfolio

    • Table Cardinal Health Inc Company Details

    • Table Cardinal Health Inc Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health Inc Radio Pharmaceutical Main Business and Markets Served

    • Table Cardinal Health Inc Radio Pharmaceutical Product Portfolio

    • Table Bayer AG Company Details

    • Table Bayer AG Radio Pharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Radio Pharmaceutical Main Business and Markets Served

    • Table Bayer AG Radio Pharmaceutical Product Portfolio

    • Figure Global Myocardial Perfusion Scan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Scan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Table North America Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure United States Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Germany Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure China Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Brazil Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Radio Pharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Australia Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Radio Pharmaceutical Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.